Company Ticker News August 17, 2021Moderna (MRNA) Begins Rare Disease Study, Inks Supply Agreement 0 0 Share
Press Release August 16, 2021Moderna Announces First Patient Dosed in Phase 1/2 Study of mRNA-3705 for Methylmalonic Acidemia 0 0 Share
Press Release August 16, 2021Moderna Announces Supply Agreement with Canada for Expanded Supply of Moderna's COVID-19 Vaccine in 2022, in 2023 and in 2024 0 0 Share
Company Ticker News August 14, 2021Moderna and Pfizer rebound after FDA authorizes third COVID-19 booster shot for immunocompromised 0 0 Share
Company Ticker News August 14, 2021The FDA allows Moderna Covid vaccine for use as booster shot: should you buy now? 0 0 Share
Company Ticker News August 14, 2021Moderna ETFs to Shine Bright on Booster Update, New Study Data 0 0 Share
Company Ticker News August 13, 2021Moderna's COVID-19 Vaccine Retains Antibodies Against Variants For 6 Months 0 0 Share
Company Ticker News August 13, 2021Moderna Says Booster Shots Are Coming. What Does It Mean for the Stock? 0 0 Share
Press Release August 13, 2021Moderna Announces FDA Authorization of Third Dose of COVID-19 Vaccine for Immunocompromised Individuals 0 0 Share